In an early stage clinical trial, Moderna’s COVID-19 vaccine produced antibodies that will help ‘neutralize’ coronavirus in patients. Moderna CEO Stéphane Bances joins Yahoo Finance’s On the Move to discuss.
from Yahoo Finance https://ift.tt/2ygEToo
from Yahoo Finance https://ift.tt/2LFcPhq
from Yahoo Finance https://ift.tt/2zKnfd0
Stocks are moving higher Monday after Moderna announced that its vaccine trial produced COVID-19 antibodies in all participants. Meanwhile, Jerome Powell told CBS’s 60 minutes ‘we’re not out of ammunition by a long shot.’ However, James McDonald, Hercules Investments CEO, thinks otherwise, he joins Yahoo Finance to discuss.
from Yahoo Finance https://ift.tt/2yd2OoJ
from Yahoo Finance https://ift.tt/3g00rXc